💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Advaxis, Inc. (ADXS)
« Back to company indexADXS Chatter Timeline
Stock Ticker for ADXS
Most Active Tweeters for ADXS
| User | Tweets |
|---|---|
| @MikeyKNOWITALL | 7 |
| @semodough | 7 |
| @TraderTexMex | 5 |
| @883dcp | 5 |
| @stock_family | 5 |
Recent Tweets for ADXS
 |
@ripster47 Typo $ADXS was .50 >.58 Penny trade that dnt work out as expected https://t.co/d4XGCvtjOc October 27th 2020, 6:10pm |
 |
@883dcp Bought back into $ADXS at $0.392 October 27th 2020, 1:10pm |
 |
@Gabbytradez $ADXS the slaughter on this is unreal ? October 27th 2020, 1:10pm |
 |
@Kevin_W81 $ADXS Tears and banana peel https://t.co/E3PXtgUS9f October 27th 2020, 11:10am |
 |
@vinny_biggs @jadid Still like the $ADXS potential? Lol.. this stock is down to the 52week high!! Is it time to buy or wait for more red? October 27th 2020, 10:10am |
|
@883dcp Tough seeing $ADXS this low, but keep in mind this was due to a bad market and being oversold. Know what you hold a… https://t.co/DIHfc277pi October 27th 2020, 10:10am |
 |
@flute41925764 $ADXS out on bad news. $JOB is a winner! October 27th 2020, 9:10am |
 |
@HealthcareBeat Advaxis down 12% despite ADXS-503 shows sustained tumor control in mid-stage lung cancer trial $ADXS $MRK https://t.co/B4MOsKh8fQ October 27th 2020, 2:10am |
 |
@ClayTraderChart VIDEO - $ADXS Stock Technical Analysis - 10-26-2020 - watch here: https://t.co/81FX8ul4Xg #stock #stocks #stocktrading October 26th 2020, 4:10pm |
|
@ripster47 $ADXS #update Closed position this morning around 58 cent for rom .51 average Bummer , was not expecting this news https://t.co/D5wXXuCJB0 October 26th 2020, 4:10pm |
 |
@singlesdoubles $ADXS long .43; positive news and this was almost .63 premarket today. Way oversold. October 26th 2020, 2:10pm |
 |
@ChartMill $ADXS: Volume is considerably higher in the last couple of days, which is what you like to see during a move up.… https://t.co/2CM9wc1Yqc October 26th 2020, 1:10pm |
 |
@neutron18 RT @BioRunUp: $ADXS Advaxis’ ADXS-503 (HOT Lung) Demonstrates Pronounced and Sustained Tumor Control in Ongoing Phase 1/2 Lung Cancer Trial October 26th 2020, 11:10am |
 |
@MarcJacksonLA $ADXS Advaxis’ ADXS-503 (HOT Lung) Demonstrates Pronounced and Sustained Tumor Control in Ongoing Phase 1/2 Lung Ca… https://t.co/MiU5bjRtRH October 26th 2020, 10:10am |
|
@Kevin_W81 $ADXS -12% Announced updated data 17% ORR https://t.co/gI9zwZZDek October 26th 2020, 10:10am |
|
@883dcp Took some really cheap shares of $ADXS at .430 October 26th 2020, 10:10am |
 |
@mehabecapital (Pre-Market) Advaxis Inc( $ADXS) trading at 0.471, -7.46% October 26th 2020, 10:10am |
 |
@RoccoLefkowitz $ADXS was a trap as suspected, management hitting the ATM and furus selling the news with their followers holding t… https://t.co/nC29YnAO4V October 26th 2020, 9:10am |
 |
@PharmaTLDN Aaaand $ADXS is down 12% + on this news. Lol https://t.co/qWRIT6WzqM October 26th 2020, 9:10am |
 |
@RelaxAndStack $ADXS well that was lame October 26th 2020, 9:10am |
 |
@i__am__JIP I was looking at $ADXS and thought, how can I miss a no brainer here!! Then I looked at the indicators I follow ..… https://t.co/5e8hhP7Vs0 October 26th 2020, 9:10am |
 |
@NolaStocks $ADXS started @ .46 October 26th 2020, 9:10am |
 |
@BWUIC $ADXS $MRK - Advaxis down 12% despite ADXS-503 shows sustained tumor control in mid-stage lung cancer trial https://t.co/Q5nmDdiL3W October 26th 2020, 9:10am |
 |
@athleticbeing $ADXS PAYtience is the Virtue ?? October 26th 2020, 9:10am |
 |
@MichaelBW80 RT @athleticbeing: $ADXS added few more , plan your trade ?? October 26th 2020, 9:10am |
|
@mehabecapital (Pre-Market) Advaxis Inc( $ADXS) trading at 0.468, -8.11% October 26th 2020, 9:10am |
 |
@Gambiste1 RT @KillerStockCall: $ADXS Advaxis' ADXS-503 (HOT Lung) Demonstrates Pronounced and Sustained Tumor Control in Ongoing Phase 1/2 Lung Cance… October 26th 2020, 8:10am |
 |
@newsfilterio Advaxis down 12% despite ADXS-503 shows sustained tumor control in mid-stage lung cancer trial $ADXS $MRK https://t.co/xOkFTrQFMB October 26th 2020, 8:10am |
|
@RelaxAndStack Adding more $ADXS once again.. day traders selling at a loss rn.. October 26th 2020, 8:10am |
 |
@MicroCapTweets $adxs opened a starter here this morning..good news and room to $1+ October 26th 2020, 8:10am |
 |
@DipDeity RT @TraderTexMex: $ADXS Disease control rate of 67% in first six evaluable patients who had progressed on KEYTRUDA Approximate 50% improve… October 26th 2020, 8:10am |
|
@RelaxAndStack $ADXS day traders selling their shares at a loss. I'll buy. News was good and price was higher Friday at close.. October 26th 2020, 8:10am |
|
@athleticbeing $ADXS added few more , plan your trade ?? October 26th 2020, 8:10am |
|
@RelaxAndStack Added $ADXS dip for a swing.. hit .60+ this morning on news.. October 26th 2020, 8:10am |
 |
@Optionsavvy $ADXS sub 1 but nice chart. has vol and flagging. imo pt .90ish https://t.co/4b9mcr73Cv October 26th 2020, 8:10am |
|
@athleticbeing $ADXS took an entry here 0.49.. plan your trade!! October 26th 2020, 8:10am |
 |
@sbwcws Advaxis announces results from combination arm of Phase 1/2 ADXS-503 study $ADXS $MRK October 26th 2020, 8:10am |
 |
@wootradez RT @stock_titan: $ADXS Advaxis’ ADXS-503 (HOT Lung) Demonstrates Pronounced and Sustained Tumor Control in Ongoing Phase 1/2 Lung Cancer Tr… October 26th 2020, 8:10am |
|
@wootradez $ADXS already poppin from the WL October 26th 2020, 8:10am |
 |
@semodough $ADXS Advaxis’ ADXS-503 (HOT Lung) Demonstrates Pronounced and Sustained Tumor Control in Ongoing Phase 1/2 Lung Ca… https://t.co/yQHsEumi3C October 26th 2020, 8:10am |
 |
@StuckInStock RT @TraderTexMex: $ADXS Advaxis’ ADXS-503 (HOT Lung) Demonstrates Pronounced and Sustained Tumor Control in Ongoing Phase 1/2 Lung Cancer T… October 26th 2020, 8:10am |
 |
@Ultra_Calls $ADXS Great news, dip bought this spot October 26th 2020, 8:10am |
|
@newsfilterio Advaxis’ ADXS-503 Demonstrates Pronounced and Sustained Tumor Control in Ongoing Phase 1/2 Lung Cancer Trial $ADXS https://t.co/J1amvqgK7P October 26th 2020, 8:10am |
 |
@TraderTexMex $ADXS Disease control rate of 67% in first six evaluable patients who had progressed on KEYTRUDA Approximate 50% i… https://t.co/5zbyO5KnwU October 26th 2020, 8:10am |
 |
@Sinteck5 $ADXS Advaxis’ ADXS-503 (HOT Lung) Demonstrates Pronounced and Sustained Tumor Control in Ongoing Phase 1/2 Lung Cancer Trial. October 26th 2020, 8:10am |
 |
@James__BondOO7 $ADXS Demonstrates Pronounced and Sustained Tumor Control in Ongoing Phase 1/2 Lung Cancer Trial #daytrading #stocks October 26th 2020, 8:10am |
 |
@BioRunUp $ADXS Advaxis’ ADXS-503 (HOT Lung) Demonstrates Pronounced and Sustained Tumor Control in Ongoing Phase 1/2 Lung Cancer Trial October 26th 2020, 8:10am |
 |
@Higgins14Steve $adxs popping October 26th 2020, 8:10am |
 |
@KillerStockCall $ADXS Advaxis' ADXS-503 (HOT Lung) Demonstrates Pronounced and Sustained Tumor Control in Ongoing Phase 1/2 Lung Ca… https://t.co/ElhHB2S4Dh October 26th 2020, 8:10am |
 |
@stock_titan $ADXS Advaxis’ ADXS-503 (HOT Lung) Demonstrates Pronounced and Sustained Tumor Control in Ongoing Phase 1/2 Lung Ca… https://t.co/BFVMc9zNQr October 26th 2020, 8:10am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2020. All rights reserved.
Get the DrugPatentWatch Daily Briefing
Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …
- ✓ Patent Expirations and Generic Entry
- ✓ 505(b)(2) & Biosimilars
- ✓ Insightful Articles and Case Studies
- ✓ Patent Litigation & Challenges
- ✓ Industry Trends
